EC Number |
Inhibitors |
Structure |
---|
2.7.11.17 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid |
- |
|
2.7.11.17 | 2-Aminopurine |
- |
|
2.7.11.17 | 2-[4-[6-(quinolin-8-yloxy)pyrimidin-4-yl]piperazin-1-yl]benzonitrile |
- |
|
2.7.11.17 | 2-[N-(2-hydroxyethyl)-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
KN-93 |
|
2.7.11.17 | 2-[N-(2-hydroxyethyl)-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
KN93 |
|
2.7.11.17 | 2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
i.e. KN-93 |
|
2.7.11.17 | 2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)amino-N-(4-chlorocinnamyl)-N-methylbenzylamine |
i.e. KN-93, competitive on the Ca2+/calmodulin binding site, CaMKII-specific inhibitor, blocks activation of the P2X3 receptor in neurons |
|
2.7.11.17 | 3-([6-(quinolin-8-yloxy)pyrimidin-4-yl]oxy)aniline |
- |
|
2.7.11.17 | 4-methyl-7-([6-[(quinolin-8-yl)oxy]pyrimidin-4-yl]oxy)-2H-1-benzopyran-2-one |
- |
|
2.7.11.17 | 6-[(5-methoxy-1H-benzimidazol-2-yl)sulfanyl]-N-(4-methoxyphenyl)pyrimidin-4-amine |
- |
|